TrialJCO precision oncology2025

Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial.

Mitsuho Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.